Related references
Note: Only part of the references are listed.Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial
Nesreen AbdelFattah AbdAllah Shehata et al.
REPRODUCTIVE SCIENCES (2020)
CINeMA: An approach for assessing confidence in the results of a network meta-analysis
Adriani Nikolakopoulou et al.
PLOS MEDICINE (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives
Andrea J. Rapkin et al.
OPEN ACCESS JOURNAL OF CONTRACEPTION (2019)
Premenstrual disorders
Kimberly Ann Yonkers et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
Romina Brignardello-Petersen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial
Cecilia Lundin et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial
Tory A. Eisenlohr-Moul et al.
DEPRESSION AND ANXIETY (2017)
Management of Premenstrual Syndrome
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2016)
Network meta-analysis: a norm for comparative effectiveness?
Julian P. T. Higgins et al.
LANCET (2015)
A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms
Jirath Wichianpitaya et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2013)
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder
Uriel Halbreich et al.
CONTRACEPTION (2012)
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome
Ellen W. Freeman et al.
CONTRACEPTION (2012)
Premenstrual Syndrome Prevalence and Fluctuation over Time: Results from a French Population-Based Survey
Julia Potter et al.
JOURNAL OF WOMENS HEALTH (2009)
Psychological Intervention for Premenstrual Syndrome: A Meta-Analysis of Randomized Controlled Trials
Jason W. Busse et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2009)
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation
TB Pearlstein et al.
CONTRACEPTION (2005)
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder
KA Yonkers et al.
OBSTETRICS AND GYNECOLOGY (2005)
Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
HU Wittchen et al.
PSYCHOLOGICAL MEDICINE (2002)
Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder
EW Freeman et al.
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2001)
Share Paper
